5'-Methylthioadenosine and Cancer: old molecules, new understanding

Related Experiment Video

Updated: Aug 17, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Yaofeng Li1, Yubo Wang2, Ping Wu1

  • 1Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Journal of Cancer
|March 12, 2019
PubMed

Insights

5'-Methylthioadenosine (MTA) shows promise in cancer research by inhibiting tumor cell growth and invasion. This review assesses MTA's effects on normal and malignant cells, highlighting its potential as an anti-cancer agent.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Altered cellular metabolism is a hallmark of cancer, a concept first described by Warburg.
  • 5'-Methylthioadenosine (MTA) is a naturally occurring nucleoside with emerging roles in cancer biology.
  • Previous research on MTA's physiological and pathophysiological roles has been limited by analytical challenges.

Purpose of the Study:

  • To review the known effects of 5'-Methylthioadenosine (MTA) on cellular processes.
  • To evaluate MTA's potential as an anti-cancer agent by examining its impact on tumor growth and function.
  • To discuss the influence of MTA on the tumor microenvironment.

Main Methods:

  • Literature review of existing studies on MTA.
  • Analysis of data on MTA's effects on normal and malignant cell proliferation, invasion, and apoptosis.
  • Assessment of MTA's role in modulating the tumor inflammatory microenvironment.

Main Results:

  • MTA demonstrates anti-tumor properties, including inhibition of tumor cell proliferation and invasion.
  • MTA can induce apoptosis in cancer cells.
  • MTA plays a role in regulating the inflammatory milieu within tumor tissues.

Conclusions:

  • 5'-Methylthioadenosine (MTA) exhibits significant anti-cancer potential through multiple mechanisms.
  • Further research into MTA and related compounds could lead to novel cancer therapies.
  • Improved analytical methods are crucial for deeper understanding of MTA's biological functions.
Keywords:
CancerMTAMTAPMetabolismPolyamine

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...